supp.fit

Branched-Chain Amino Acids: study protocols

106 study groups say how much Branched-Chain Amino Acids participants took a day. These are the doses the studies gave. They are not a recommendation.

Branched-Chain Amino Acids: what the research found →

Dose per serving from products

298 products in our catalogue print how much Branched-Chain Amino Acids a serving holds.

Most common: 1 g to 2.5 g, 32% of 298 products.

Dose per servingProducts
100 mg or less
12
100 mg to 250 mg
15
250 mg to 500 mg
8
500 mg to 1 g
40
1 g to 2.5 g
96
2.5 g to 5 g
83
5 g to 10 g
37
over 10 g
7

Dose per serving from research

68 study groups in 53 studies say how much Branched-Chain Amino Acids participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 10 g to 25 g, 32% of 68 study groups.

Daily doseStudy groups
2.5 g or less
4
2.5 g to 5 g
7
5 g to 10 g
21
10 g to 25 g
22
25 g to 50 g
5
50 g to 100 g
7
over 100 g
2

Commonly used together

43 of 106 study groups took Branched-Chain Amino Acids with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Leucine
17
Arginine
4
protein
4
Citrulline
3
Zinc
3

106 study groups

Study
Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis
2005 · BCAA group · Patients with decompensated cirrhosis; age and sex not reported
12 g2 years—
Branched-chain amino acids suppress the cumulative recurrence of hepatocellular carcinoma under conditions of insulin-resistance
2013 · BCAA-treated group · People with hepatocellular carcinoma after local curative radiofrequency ablation; age and sex range not specified
12 g5 years—
A Randomized Trial of Nutrition and Exercise Treatment in Patients With Pancreatic and Non-Small Cell Lung Cancer (NEXTAC-TWO)
2025 · NEXTAC arm · Adults aged 70 years or older with advanced pancreatic cancer or non-small cell lung cancer, scheduled for systemic cancer therapy
2.5 g12 weeks64
Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial. The San-in Group of Liver Surgery
1997 · oral BCAAs · Patients after curative resection of hepatocellular carcinoma, including patients with cirrhosis
100 g1 year75
Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis
2018 · BCAAs+HPHF diet intervention group · Patients with cirrhosis
110 g26 weeks37
Effectiveness of Protein-enriched oral nutritional supplements on muscle function in middle-aged and elderly women: A randomized controlled trial
2025 · test group · Women aged 50–80 years; generally healthy, without clinical malnutrition or a stated diagnosed condition
4 g12 weeks33
Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group
1990 · branched-chain amino acids · Adults with cirrhosis and chronic hepatic encephalopathy; age and sex not reported
240 mg/kg90 days30
A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: validation using prognostic markers for pre-liver transplant status
2009 · oral BCAA group · Adults with Child class A cirrhosis without major complications
12.5 g1168 days27
Branched-chain amino acids supplementation improves liver frailty index in frail compensated cirrhotic patients: a randomized controlled trial
2023 · BCAA group · Adults aged 18–75 with frail, stable Child-Pugh A or B cirrhosis
100 g16 weeks27
Effects of branched-chain amino acids on changes in body composition during the recovery period following tonsillectomy
2025 · Experimental · Adults aged 20–40 scheduled for tonsillectomy; men and women without metabolic or bleeding disorders
8 g3 weeks24
Acute dopamine depletion with branched chain amino acids decreases auditory top-down event-related potentials in healthy subjects
2009 · BCAA · healthy men, mean age 35.5 years
60 g1 day22
The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention-A pilot study
2017 · active intervention · Adults with liver cirrhosis without clinically manifest hepatic encephalopathy
17 g90 days22
Effects of Branched-Chain Amino Acids on Skeletal Muscle, Glycemic Control, and Neuropsychological Performance in Elderly Persons with Type 2 Diabetes Mellitus: An Exploratory Randomized Controlled Trial
2022 · BCAA group · Adults aged 65 to under 80 years with type 2 diabetes
8 g24 weeks21
Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men
2003 · high-dose branched-chain amino acids · Men with psychiatric disorders and tardive dyskinesia, with long histories of antipsychotic treatment
666 mg/kg3 weeks18
Oral supplementation of branched-chain amino acid improves nutritional status in elderly patients on chronic haemodialysis
2001 · BCAA supplementation · Adults aged over 70 years with malnutrition, anorexia and chronic haemodialysis
12 g26 weeks14
Branched-chain amino acid supplementation before squat exercise and delayed-onset muscle soreness
2010 · BCAA trial · 12 young, healthy, untrained women
100 mg/kg1 day12
Effect of Timing of Branched-Chain Amino Acid Supplementation on Muscle Recovery after Resistance Training in Healthy Males
2025 · BCAA-PRE group · Healthy male college students, mean age about 23 years, with no athletic training experience
40 mg/kg1 day12
Effect of Timing of Branched-Chain Amino Acid Supplementation on Muscle Recovery after Resistance Training in Healthy Males
2025 · BCAA-POST group · Healthy male college students, mean age about 23 years, with no athletic training experience
40 mg/kg1 day12
Branched-chain amino acid therapy for spinocerebellar degeneration: a pilot clinical crossover trial
1999 · BCAA-rich solution · Adults with spinocerebellar degeneration; 7 male and 4 female, mean age 60 years
200 mL7 days11
Branched-chain aminoacid supplementation attenuates a decrease in power-producing ability following acute strength training
2016 · BCAA · Resistance-trained males
20 g1 day11
Branched-Chain Amino Acid Supplementation Enhances Substrate Metabolism, Exercise Efficiency and Reduces Post-Exercise Fatigue in Active Young Males
2025 · BCAA group · Healthy, active male college students; young adults, with no diagnosed condition stated
400 mg/kg4 days11
Effect of acute and chronic branched-chain amino acids on energy metabolism and muscle performance
2003 · chronic BCAA supplementation · 10 healthy male volunteers
14.4 g30 days10
The effect of branched chain amino acids on psychomotor performance during treadmill exercise of changing intensity simulating a soccer game
2011 · BCAA trial · Male soccer players; age and health condition not specified
7 g1 day10
Effect of Branched-Chain Amino Acid Supplementation on Recovery Following Acute Eccentric Exercise
2018 · BCAA group · Young resistance-trained males, mean age 22.3 years, completing an acute eccentric exercise protocol
220 mg/kg8 days10
Omega-3 fatty acids enhance the beneficial effect of BCAA supplementation on muscle function following eccentric contractions
2022 · BCAA group · Healthy, untrained men aged 19–21 years
9.6 g3 days10
Additional effects of taurine on the benefits of BCAA intake for the delayed-onset muscle soreness and muscle damage induced by high-intensity eccentric exercise
2013 · BCAA alone · Untrained male volunteers
9.6 g18 days9
The effects of bolus supplementation of branched-chain amino acids on skeletal muscle mass, strength, and function in patients with rheumatic disorders during glucocorticoid treatment
2017 · BCAA (+) group · Patients with rheumatic disorders treated with prednisolone at ≥10 mg/day; age and sex not reported
12 g12 weeks9
Effects of a branched-chain amino acid drink in mania
2003 · BCAA · Patients with mania
60 g7 days—
In a single-blind, matched group design: branched-chain amino acid supplementation and resistance training maintains lean body mass during a caloric restricted diet
2016 · BCAA group · Resistance-trained males aged 21–28 years, following a calorically restricted diet and resistance-training program; no diagnosed condition stated
28 g8 weeks—
Effect of BCAA supplement timing on exercise-induced muscle soreness and damage: a pilot placebo-controlled double-blind study
2018 · PRE group · Young men aged 21.5±0.4 years performing eccentric exercise
9.6 g7 days—
Effect of BCAA supplement timing on exercise-induced muscle soreness and damage: a pilot placebo-controlled double-blind study
2018 · POST group · Young men aged 21.5±0.4 years performing eccentric exercise
9.6 g7 days—
Head Injury Treatment With Healthy and Advanced Dietary Supplements: A Pilot Randomized Controlled Trial of the Tolerability, Safety, and Efficacy of Branched Chain Amino Acids in the Treatment of Concussion in Adolescents and Young Adults
2024 · 15 g BCAA treatment daily · Participants aged 11–34 with concussion
15 g3 weeks—
Head Injury Treatment With Healthy and Advanced Dietary Supplements: A Pilot Randomized Controlled Trial of the Tolerability, Safety, and Efficacy of Branched Chain Amino Acids in the Treatment of Concussion in Adolescents and Young Adults
2024 · 30 g BCAA treatment daily · Participants aged 11–34 with concussion
30 g3 weeks—
Head Injury Treatment With Healthy and Advanced Dietary Supplements: A Pilot Randomized Controlled Trial of the Tolerability, Safety, and Efficacy of Branched Chain Amino Acids in the Treatment of Concussion in Adolescents and Young Adults
2024 · 45 g BCAA treatment daily · Participants aged 11–34 with concussion
45 g3 weeks—
Head Injury Treatment With Healthy and Advanced Dietary Supplements: A Pilot Randomized Controlled Trial of the Tolerability, Safety, and Efficacy of Branched Chain Amino Acids in the Treatment of Concussion in Adolescents and Young Adults
2024 · 54 g BCAA treatment daily · Participants aged 11–34 with concussion
54 g3 weeks—
Effects of branched chain amino acids, l-citrulline, and alpha-glycerylphosphorylcholine supplementation on exercise performance in trained cyclists: a randomized crossover trial
2023 · supplement · Men aged 30–60 who were trained cyclists with at least 5 years of consistent cycling training
8 g7 days30
The Effect of Branched Chain Amino Acids-Enriched Nutritional Supplements on Activities of Daily Living and Muscle Mass in Inpatients with Gait Impairments: A Randomized Controlled Trial
2019 · RJ group · Adult inpatients aged 20 years or older with gait impairments admitted to acute and convalescent rehabilitation wards
5 g58 days29
Glycine increases fat-free mass in malnourished haemodialysis patients: a randomized double-blind crossover trial
2021 · BCAA supplementation · Adults with protein-energy wasting undergoing chronic haemodialysis; mean age 61.2 years among analysed participants, women and men
14 g120 days27
Branched-chain amino acids and arginine improve performance in two consecutive days of simulated handball games in male and female athletes: a randomized trial
2015 · AA trial (BCAA + arginine) · Well-trained male and female handball players aged about 20–21 years, competing at national or international level, without known cardiovascular disease risks or musculoskeletal injuries
170 mg/kg2 days22
Branched-chain amino acid supplementation improves cycling performance in untrained cyclists
2021 · BCAA · Recreationally active men; mean age 24.7 years; no specific condition stated
84 mg/kg1 day18
Omega-3 fatty acids enhance the beneficial effect of BCAA supplementation on muscle function following eccentric contractions
2022 · BCAA+FO group · Healthy, untrained men aged 19–20 years
9.6 g61 days10
Additional effects of taurine on the benefits of BCAA intake for the delayed-onset muscle soreness and muscle damage induced by high-intensity eccentric exercise
2013 · TAU and BCAA · Untrained male volunteers
9.6 g18 days9
Prevention of perceptual-motor decline by branched-chain amino acids, arginine, citrulline after tennis match
2017 · AA trial · Nine male tennis players
170 mg/kg1 day9
The effects of a branched chain amino acid mixture supplemented with tryptophan on biochemical indices of neurotransmitter function and decision-making
2005 · BCAA/TRP mixture · Healthy adult volunteers; age and sex not specified
60 g1 day—
The effects of protein and amino acid supplementation on performance and training adaptations during ten weeks of resistance training
2006 · WBG · Resistance-trained males, mean age 31 years, undergoing resistance training
3 g10 weeks—
[Impact of glutamine, eicosapntemacnioc acid, branched-chain amino acid supplements on nutritional status and treatment compliance of esophageal cancer patients on concurrent chemoradiotherapy and gastric cancer patients on chemotherapy]
2015 · experimental group · Esophageal and gastric cancer patients receiving concurrent chemoradiotherapy or chemotherapy
8 g——
Effects of Oral L-Carnitine on Liver Functions after Transarterial Chemoembolization in Intermediate-Stage HCC Patients
2015 · Control group, BCAA+ patients · Japanese adults with intermediate-stage hepatocellular carcinoma and liver cirrhosis undergoing TACE; already receiving BCAA granules
4 g14 weeks—
The Weight Loss Effects of Branched Chain Amino Acids and Vitamin B6: A Randomized Controlled Trial on Obese and Overweight Women
2018 · BCAA with vitamin B6 · Overweight and obese women (BMI 25–34.9 kg/m²)
6 g4 weeks—
Combined Effect of Arginine, Valine, and Serine on Exercise-Induced Fatigue in Healthy Volunteers: A Randomized, Double-Blinded, Placebo-Controlled Crossover Study
2019 · AA granule · Healthy men aged 30–59 years
2.2 g2 weeks39
The Combined Use of Hydroxymethylbutyrate and Branched-Chain Amino Acids to Counteract Uremic Sarcopenia
2026 · FFSMP · Adults aged 45–80, men and women, with end-stage kidney disease receiving hemodialysis
5 g90 days24
The Effects of Timing of a Leucine-Enriched Amino Acid Supplement on Body Composition and Physical Function in Stroke Patients: A Randomized Controlled Trial
2020 · breakfast group · Adults aged 40 years and older admitted for rehabilitation after cerebral infarction, cerebral hemorrhage, or subarachnoid hemorrhage
125 mL60 days23
The Effects of Timing of a Leucine-Enriched Amino Acid Supplement on Body Composition and Physical Function in Stroke Patients: A Randomized Controlled Trial
2020 · post-exercise group · Adults aged 40 years and older admitted for rehabilitation after cerebral infarction, cerebral hemorrhage, or subarachnoid hemorrhage
125 mL60 days23
A randomized, double-blind, placebo-controlled, repeated-dose pilot study of the safety, tolerability, and preliminary effects of a cannabidiol (CBD)- and cannabigerol (CBG)-based beverage powder to support recovery from delayed onset muscle soreness (DOMS)
2023 · Active formulation · Exercise-trained adults aged 18–65 in good health who reported exercising at least 3 times weekly for at least 30 minutes per session during the prior year; participants underwent experimental induction of delayed onset muscle soreness.
7.6 g4 days20
Branched-chain amino acids, arginine, citrulline alleviate central fatigue after 3 simulated matches in taekwondo athletes: a randomized controlled trial
2016 · AA trial · Male taekwondo athletes, age 20.0 ± 0.8 years, competing at national or international level
170 mg/kg1 day12
Effects of Oral L-Carnitine on Liver Functions after Transarterial Chemoembolization in Intermediate-Stage HCC Patients
2015 · L-carnitine group, BCAA+ patients · Japanese adults with intermediate-stage hepatocellular carcinoma and liver cirrhosis undergoing TACE; already receiving BCAA granules
4 g14 weeks—
Branched Chain Amino Acid Supplementation to a Hypocaloric Diet Does Not Affect Resting Metabolic Rate but Increases Postprandial Fat Oxidation Response in Overweight and Obese Adults after Weight Loss Intervention
2021 · BCAA · Chinese men and women aged 21–45 years with overweight or obesity (BMI 25–36 kg/m²), without existing medical conditions
100 mg/kg16 weeks35
A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma
2009 · BCAA group · Patients with liver cirrhosis and hepatocellular carcinoma undergoing trans-arterial chemoembolization; age and sex not reported
50 g15 days28
Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment
2015 · BCAA group (study 2) · Adults with cirrhosis receiving endoscopic treatment for esophageal varices who had already received BCAA for at least a month
12 g50 days24
Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment
2015 · BCAA-EN group (study 2) · Adults with cirrhosis receiving endoscopic treatment for esophageal varices who had already received BCAA for at least a month
12 g50 days24
Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment
2015 · BCAA-EN group (study 1) · Adults with cirrhosis receiving endoscopic treatment for esophageal varices, not receiving BCAA before the study
12 g7 days16
A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function
2002 · 10 g branch chain amino acids · 12 healthy volunteers
10 g1 day12
A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function
2002 · 30 g branch chain amino acids · 12 healthy volunteers
30 g1 day12
A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function
2002 · 60 g branch chain amino acids · 12 healthy volunteers
60 g1 day12
Effect of acute and chronic branched-chain amino acids on energy metabolism and muscle performance
2003 · acute BCAA group · 12 healthy male volunteers
14.4 g2 days12
Branched-chain amino acids reduce hepatic iron accumulation and oxidative stress in hepatitis C virus polyprotein-expressing mice
2015 · BCAA group · Adults aged 65 years or older with HCV-related advanced fibrosis and low BCAA-to-tyrosine ratio; men and women
12 g48 weeks12
The Effects of Omega-3 and Branched-Chain Amino Acids Supplementation on Serum Apoptosis Markers Following Acute Resistance Exercise in Old Men
2019 · BCAA supplementation · Men aged 62.8 ± 2.2 years undergoing acute resistance exercise
20 g7 days11
Influence of branched-chain amino acid supplementation on urinary protein metabolite concentrations after swimming
2006 · BCAA group · Male university students aged 19–22 years majoring in physical education
12 g15 days10
The biphasic activity of autophagy and heat shock protein response in peripheral blood mononuclear cells following acute resistance exercise in resistance-trained males
2024 · BCAA supplementation group · Resistance-trained males, mean age 22.3 years
220 mg/kg8 days10
Effects of high-protein intake on bone turnover in long-term bed rest in women
2017 · HiPROT · Women participating in a 60-day head-down-tilt bed-rest study; age and health status not specified
720 mg60 days8
Short-term effects of branched-chain amino acids on liver function tests in cirrhotic patients
2000 · group I · Ambulatory patients with cirrhosis; age and sex not reported
150 g4 weeks—
Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine
2004 · 20 mg·kg⁻¹·day⁻¹ BCAA mixture · Patients with classical maple syrup urine disease; age and sex not reported
20 mg/kg——
Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine
2004 · 30 mg·kg⁻¹·day⁻¹ BCAA mixture · Patients with classical maple syrup urine disease; age and sex not reported
30 mg/kg——
Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine
2004 · 50 mg·kg⁻¹·day⁻¹ BCAA mixture · Patients with classical maple syrup urine disease; age and sex not reported
50 mg/kg——
Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine
2004 · 60 mg·kg⁻¹·day⁻¹ BCAA mixture · Patients with classical maple syrup urine disease; age and sex not reported
60 mg/kg——
Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine
2004 · 70 mg·kg⁻¹·day⁻¹ BCAA mixture · Patients with classical maple syrup urine disease; age and sex not reported
70 mg/kg——
Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine
2004 · 90 mg·kg⁻¹·day⁻¹ BCAA mixture · Patients with classical maple syrup urine disease; age and sex not reported
90 mg/kg——
Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine
2004 · 110 mg·kg⁻¹·day⁻¹ BCAA mixture · Patients with classical maple syrup urine disease; age and sex not reported
110 mg/kg——
Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine
2004 · 130 mg·kg⁻¹·day⁻¹ BCAA mixture · Patients with classical maple syrup urine disease; age and sex not reported
130 mg/kg——
Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosis
2009 · BCAA group · Patients with HCV-related cirrhosis and serum albumin below 4.0 g/dl
14.2 g2 years—
Effects of branched-chain amino acids on glucose metabolism in obese, prediabetic men and women: a randomized, crossover study
2019 · BCAA supplement · obese men and women with prediabetes; ages not reported
20 g4 weeks—
Effect of Oral Branched-Chain Amino Acids on Serum Albumin Concentration in Heart Failure Patients with Hypoalbuminemia: Results of a Preliminary Study
2018 · BCAA group · Adults aged 20 years or older hospitalized with decompensated heart failure and hypoalbuminemia (serum albumin below 3.5 g/dL)
12 g18 days7
Plasma levels of adrenaline, noradrenaline, dopamine, serotonin, and cortisol in sarcopenia: comparison with non-sarcopenic individuals and the impact of resistance exercise and nutrition interventions
2025 · Combined exercise and nutritional intervention (sarcopenic participants; early versus delayed intervention trial) · Adults older than 65 years with sarcopenia
7.2 g12 weeks57
Effects of branched-chain amino acids and zinc-enriched nutrients on prognosticators in HCV-infected patients: a multicenter randomized controlled trial
2015 · supplement group · HCV-infected patients
6.4 g60 days26
Cardiac atrophy in women following bed rest
2007 · protein plus branched-chain amino acid supplementation · Healthy young women, mean age 32.1 years, undergoing 60 days of head-down tilt bed rest
7.2 g60 days8
The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach
2005 · valine intake 5 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men
5 mg/kg7 days—
The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach
2005 · valine intake 10 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men
10 mg/kg7 days—
The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach
2005 · valine intake 15 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men
15 mg/kg7 days—
The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach
2005 · valine intake 20 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men
20 mg/kg7 days—
The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach
2005 · valine intake 25 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men
25 mg/kg7 days—
The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach
2005 · valine intake 30 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men
30 mg/kg7 days—
The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach
2005 · valine intake 35 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men
35 mg/kg7 days—
Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes
1991 · Phase 1: leucine 40 mg/kg/day, valine 80 mg/kg/day, isoleucine 62 mg/kg/day · Healthy young adult men; six subjects were in phase 1
80 mg/kg5 days—
Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes
1991 · Phase 1: leucine 15 mg/kg/day, valine 80 mg/kg/day, isoleucine 62 mg/kg/day · Healthy young adult men; six subjects were in phase 1
80 mg/kg5 days—
Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes
1991 · Phase 1: leucine 40 mg/kg/day, valine 20 mg/kg/day, isoleucine 62 mg/kg/day · Healthy young adult men; six subjects were in phase 1
20 mg/kg5 days—
Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes
1991 · Phase 1: leucine 15 mg/kg/day, valine 20 mg/kg/day, isoleucine 62 mg/kg/day · Healthy young adult men; six subjects were in phase 1
20 mg/kg5 days—
Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes
1991 · Phase 2: leucine 15 mg/kg/day, valine 20 mg/kg/day, isoleucine 62 mg/kg/day · Healthy young adult men; five subjects were in phase 2
20 mg/kg5 days—
Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes
1991 · Phase 2: leucine 40 mg/kg/day, valine 20 mg/kg/day, isoleucine 20 mg/kg/day · Healthy young adult men; five subjects were in phase 2
20 mg/kg5 days—
Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes
1991 · Phase 2: leucine 15 mg/kg/day, valine 20 mg/kg/day, isoleucine 20 mg/kg/day · Healthy young adult men; five subjects were in phase 2
20 mg/kg5 days—
Enhanced serum levels of tumor necrosis factor-α, interleukin-1β, and -6 in sarcopenia: alleviation through exercise and nutrition intervention
2023 · Early intervention group · Adults aged 65 years and older with sarcopenia
7.2 g12 weeks—
Enhanced serum levels of tumor necrosis factor-α, interleukin-1β, and -6 in sarcopenia: alleviation through exercise and nutrition intervention
2023 · Delayed intervention group · Adults aged 65 years and older with sarcopenia
7.2 g12 weeks—
A multi-nutrient supplement reduced markers of inflammation and improved physical performance in active individuals of middle to older age: a randomized, double-blind, placebo-controlled study
2011 · BioCharge multi-nutrient supplement · Healthy, recreationally active men and women aged 40–70 years
3 g4 weeks31
Dileucine-supplemented essential amino acids support whole-body anabolism after resistance exercise and serum-stimulated cell-based anabolism
2025 · Branched-chain amino acid (BCAA) supplement · Healthy recreationally active adults, 27.0 ± 4.7 years old; 8 men and 4 women
1.5 g1 day12
Safety, Tolerability, and Physiological Effects of AXA1665, a Novel Composition of Amino Acids, in Subjects With Child-Pugh A and B Cirrhosis
2020 · AXA1665 14.7 g t.i.d. + SOC (high-dose group) · Adults aged 18–75, male and female, with Child–Pugh A or B cirrhosis
6.67 g15 days9
The effect of multi-ingredient intra- versus extra-cellular buffering supplementation combined with branched-chain amino acids and creatine on exercise-induced ammonia blood concentration and aerobic capacity in taekwondo athletes
2021 · BA (intracellular buffering) · Elite taekwondo athletes aged 18–35 years, male and female, healthy and highly trained
11 g8 weeks9
The effect of multi-ingredient intra- versus extra-cellular buffering supplementation combined with branched-chain amino acids and creatine on exercise-induced ammonia blood concentration and aerobic capacity in taekwondo athletes
2021 · ALK (extracellular buffering) · Elite taekwondo athletes aged 18–35 years, male and female, healthy and highly trained
11 g8 weeks9
Safety, Tolerability, and Physiological Effects of AXA1665, a Novel Composition of Amino Acids, in Subjects With Child-Pugh A and B Cirrhosis
2020 · AXA1665 4.9 g t.i.d. + SOC (low-dose group) · Adults aged 18–75, male and female, with Child–Pugh A or B cirrhosis
6.67 g15 days8